These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1248896)

  • 1. Tumor-bound immunoglobulins. I. Further analysis of the characteristics of binding of immunoglobulins to in vivo-grown tumor cells.
    Dorval G; Witz IP; Klein E; Wigzell H
    Int J Cancer; 1976 Jan; 17(1):109-19. PubMed ID: 1248896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine natural anti-tumor antibodies. I. Rapid in vivo binding of natural antibody by tumor cells in syngeneic mice.
    Wolosin LB; Greenberg AH
    Int J Cancer; 1979 Apr; 23(4):519-29. PubMed ID: 437926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte membrane-associated immunoglobulins during malaria infection of mice.
    Lustig HJ; Nussenzweig V; Nussenzweig RS
    J Immunol; 1977 Jul; 119(1):210-6. PubMed ID: 326956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a 30 kDa immunoglobulin binding protein from Pseudomonas maltophilia.
    Grover S; McGee ZA; Odell WD
    J Immunol Methods; 1991 Aug; 141(2):187-97. PubMed ID: 1880425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin bound in vivo to Fc receptor-positive cells in human central nervous system tumors.
    Wood GW; Morantz RA; Tilzer SA; Gollahon KA
    J Natl Cancer Inst; 1980 Mar; 64(3):411-8. PubMed ID: 6986495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C.
    Kumagai K; Abo T; Sekizawa T; Sasaki M
    J Immunol; 1975 Oct; 115(4):982-7. PubMed ID: 240887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor bound immunoglobulins: the relationship between the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies, and the expression of immune complex receptors.
    Braslawsky G; Ran M; Witz IP
    Int J Cancer; 1976 Jul; 18(1):116-21. PubMed ID: 947858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
    Hurwitz E; Schechter B; Arnon R; Sela M
    Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane and internalized immunoglobulins of lymph node cells studied with conjugates of antibody or its Fab fragments with horseradish peroxidase.
    Antoine JC; Avrameas S; Gonatas NK; Stieber A; Gonatas JO
    J Cell Biol; 1974 Oct; 63(1):12-23. PubMed ID: 4608522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-bound immunoglobulins: an in vivo phenomenon of masked specificity.
    Dorval G; Wilz IP; Klein E; Wigzell H
    J Natl Cancer Inst; 1976 Mar; 56(3):523-7. PubMed ID: 56447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-immune immunoglobulin binding by "Haemophilus somnus".
    Widders PR; Smith JW; Yarnall M; McGuire TC; Corbeil LB
    J Med Microbiol; 1988 Aug; 26(4):307-11. PubMed ID: 3398035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
    Manson LA
    Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency.
    Ran M; Katz B; Kimchi N; Halachmi E; Teillaud JL; Even J; Berko-Flint Y; Atlas E; Fridman WH; Witz IP
    Cancer Res; 1991 Jan; 51(2):612-8. PubMed ID: 1845956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-bound immunoglobulins. The in vitro fixation of radioiodine-labelled anti-immunoglobulin reagents by tumour cells.
    Witz IP; Kinamon S; Ran M; Klein G
    Clin Exp Immunol; 1974 Mar; 16(3):321-33. PubMed ID: 4549685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.
    McCool D; Birshtein BK; Painter RH
    J Immunol; 1985 Sep; 135(3):1975-80. PubMed ID: 3860563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships of surface immunoglobulin and Fc receptors on mouse B lymphocytes.
    Abbas AK; Unanue ER
    J Immunol; 1975 Dec; 115(6):1665-71. PubMed ID: 1102608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
    Phillips NE; Gravel KA; Tumas K; Parker DC
    J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies.
    Ran M; Klein G; Witz IP
    Int J Cancer; 1976 Jan; 17(1):90-7. PubMed ID: 55397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking and redistribution ("capping") of antigen receptors on T and B lymphocytes by anti-immunoglobulin antibody.
    Roelants G; Forni L; Pernis B
    J Exp Med; 1973 Apr; 137(4):1060-77. PubMed ID: 4571327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.